These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

65 related items for PubMed ID: 8720549

  • 1. Moral crisis.
    Long LL.
    J Okla State Med Assoc; 1996 Jan; 89(1):5. PubMed ID: 8720549
    [No Abstract] [Full Text] [Related]

  • 2. Treatment of acute migraine with sumatriptan--response in 40 consecutive patients.
    Blumenthal HJ, Weisz MA, Burk S.
    J Okla State Med Assoc; 1996 Jan; 89(1):7-10. PubMed ID: 8720550
    [Abstract] [Full Text] [Related]

  • 3. [Sumatriptan in treatment of migraine and its efficacy and tolerance in self-assessment by patients].
    Prusiński A, Barliński J.
    Pol Tyg Lek; 1996 Mar; 51(10-13):187-9. PubMed ID: 8927561
    [No Abstract] [Full Text] [Related]

  • 4. [The efficacy of subcutaneous sumatriptan for the treatment of migraine attack].
    Stepień A.
    Pol Merkur Lekarski; 1999 Jun; 6(36):326-7. PubMed ID: 10481546
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A randomized, double-blind, placebo-controlled trial of the efficacy and tolerability of a 4-mg dose of subcutaneous sumatriptan for the treatment of acute migraine attacks in adults.
    Wendt J, Cady R, Singer R, Peters K, Webster C, Kori S, Byrd S.
    Clin Ther; 2006 Apr; 28(4):517-26. PubMed ID: 16750463
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Sumatriptan and naproxen sodium for the acute treatment of migraine.
    Smith TR, Sunshine A, Stark SR, Littlefield DE, Spruill SE, Alexander WJ.
    Headache; 2005 Sep; 45(8):983-91. PubMed ID: 16109111
    [Abstract] [Full Text] [Related]

  • 12. [18 months long-term analysis of effectiveness, safety and tolerance of sumatriptan s.c. in acute therapy of migraine attacks].
    Göbel H, Stolze H, Heinze A, Dworschak M, Heuss D, Christiani K, Lindner V.
    Nervenarzt; 1996 Jun; 67(6):471-83. PubMed ID: 8767202
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Evaluation of efficacy and tolerance sumatriptan at a dose of 50 mg in treatment of migraine attack].
    Prusiński A, Król F.
    Pol Merkur Lekarski; 1998 Mar; 4(21):158-61. PubMed ID: 9640070
    [Abstract] [Full Text] [Related]

  • 15. [Treatment of acute migraine with sumatriptan. Clinical experiences with advantages and disadvantages].
    Dahlöf C, Ekbom K, Persson L.
    Lakartidningen; 1993 Sep 22; 90(38):3195-6, 3200. PubMed ID: 8231472
    [No Abstract] [Full Text] [Related]

  • 16. Oral sumatriptan for the acute treatment of probable migraine: first randomized, controlled study.
    Tepper SJ, Cady R, Dodick D, Freitag FG, Hutchinson SL, Twomey C, Kuhn TA.
    Headache; 2006 Jan 22; 46(1):115-24. PubMed ID: 16412159
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Almotriptan improves response rates when treatment is within 1 hour of migraine onset.
    Dowson AJ, Massiou H, Lainez JM, Cabarrocas X.
    Headache; 2004 Apr 22; 44(4):318-22. PubMed ID: 15109355
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Pilot study evaluating preference for 3-mg versus 6-mg subcutaneous sumatriptan.
    Landy SH, McGinnis JE, McDonald SA.
    Headache; 2005 Apr 22; 45(4):346-9. PubMed ID: 15836571
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.